Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Debt to Equity (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Debt to Equity for 4 consecutive years, with $0.27 as the latest value for Q4 2025.

  • Quarterly Debt to Equity fell 38.58% to $0.27 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.27 through Dec 2025, down 38.58% year-over-year, with the annual reading at $0.27 for FY2025, 38.58% down from the prior year.
  • Debt to Equity for Q4 2025 was $0.27 at Orchestra BioMed Holdings, down from $0.32 in the prior quarter.
  • The five-year high for Debt to Equity was $48.76 in Q2 2025, with the low at $0.1 in Q1 2023.
  • Average Debt to Equity over 4 years is $5.69, with a median of $0.27 recorded in 2025.
  • Peak annual rise in Debt to Equity hit 38.58% in 2025, while the deepest fall reached 38.58% in 2025.
  • Over 4 years, Debt to Equity stood at $0.22 in 2022, then plummeted by 45.33% to $0.12 in 2023, then surged by 259.85% to $0.43 in 2024, then tumbled by 38.58% to $0.27 in 2025.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.27, $0.32, and $48.76 for Q4 2025, Q3 2025, and Q2 2025 respectively.